Weak localization of disordered quasiparticles in the mixed superconducting state

Starting from a random matrix model, we construct the low-energy effective field theory for the noninteracting gas of quasiparticles of a disordered superconductor in the mixed state. The theory is a nonlinear sigma model, with the order parameter field being a supermatrix whose form is determined solely on symmetry grounds. The weak localization correction to the field-axis thermal conductivity is computed for a dilute array of s-wave vortices near the lower critical field H_c1. We propose that weak localization effects, cut off at low temperatures by the Zeeman splitting, are responsible for the field dependence of the thermal conductivity seen in recent high-T_c experiments by Aubin et al.Comment: RevTex, 8 pages, 1 eps figure, typos correcte

The types of Mott insulator

There are two classes of Mott insulators in nature, distinguished by their responses to weak doping. With increasing chemical potential, Type I Mott insulators undergo a first order phase transition from the undoped to the doped phase. In the presence of long-range Coulomb interactions, this leads to an inhomogeneous state exhibiting ``micro-phase separation.'' In contrast, in Type II Mott insulators charges go in continuously above a critical chemical potential. We show that if the insulating state has a broken symmetry, this increases the likelihood that it will be Type I. There exists a close analogy between these two types of Mott insulators and the familiar Type I and Type II superconductors

Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019 : a systematic analysis from the Global Burden of Disease Study 2019

Background Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. Methods We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global Burden of Diseases, Injuries, and Risk Factors Study. We modelled multiple smoking-related indicators from 3625 nationally representative surveys. We completed systematic reviews and did Bayesian meta-regressions for 36 causally linked health outcomes to estimate non-linear dose-response risk curves for current and former smokers. We used a direct estimation approach to estimate attributable burden, providing more comprehensive estimates of the health effects of smoking than previously available. Findings Globally in 2019, 1.14 billion (95% uncertainty interval 1.13-1.16) individuals were current smokers, who consumed 7.41 trillion (7.11-7.74) cigarette-equivalents of tobacco in 2019. Although prevalence of smoking had decreased significantly since 1990 among both males (27.5% [26. 5-28.5] reduction) and females (37.7% [35.4-39.9] reduction) aged 15 years and older, population growth has led to a significant increase in the total number of smokers from 0.99 billion (0.98-1.00) in 1990. Globally in 2019, smoking tobacco use accounted for 7.69 million (7.16-8.20) deaths and 200 million (185-214) disability-adjusted life-years, and was the leading risk factor for death among males (20.2% [19.3-21.1] of male deaths). 6.68 million [86.9%] of 7.69 million deaths attributable to smoking tobacco use were among current smokers. Interpretation In the absence of intervention, the annual toll of 7.69 million deaths and 200 million disability-adjusted life-years attributable to smoking will increase over the coming decades. Substantial progress in reducing the prevalence of smoking tobacco use has been observed in countries from all regions and at all stages of development, but a large implementation gap remains for tobacco control. Countries have a dear and urgent opportunity to pass strong, evidence-based policies to accelerate reductions in the prevalence of smoking and reap massive health benefits for their citizens. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe